Twelve‐month follow‐up results from the SIRONA 2 clinical trial
Abstract Aims In the SIRONA 2 trial, the safety and efficacy of pulmonary artery (PA) pressure (PAP)‐guided heart failure (HF) management using a novel PAP sensor were assessed at 30 and 90 days, respectively, and both endpoints were met. The current study examines the prespecified secondary endpoin...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2024-04-01
|
| シリーズ: | ESC Heart Failure |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/ehf2.14657 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|